HUTCHMED (China) Limited (LON:HCM – Get Free Report) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 267.29 ($3.33) and traded as low as GBX 267 ($3.32). HUTCHMED shares last traded at GBX 268 ($3.34), with a volume of 66,901 shares.
HUTCHMED Stock Up 0.4 %
The company has a market capitalization of £2.31 billion, a P/E ratio of 2,700.00 and a beta of 0.68. The firm’s 50 day moving average price is GBX 253.99 and its two-hundred day moving average price is GBX 267.31. The company has a current ratio of 2.72, a quick ratio of 2.97 and a debt-to-equity ratio of 11.59.
About HUTCHMED
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.
Featured Articles
- Five stocks we like better than HUTCHMED
- Stock Dividend Cuts Happen Are You Ready?
- Comprehensive PepsiCo Stock Analysis
- Canadian Penny Stocks: Can They Make You Rich?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for HUTCHMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHMED and related companies with MarketBeat.com's FREE daily email newsletter.